Consistent with our finding, a case–control study reported that fasting blood insulin levels were higher in non-diabetic colorectal cancer patients compared with obesity-matched controls and that FI levels were associated with increased colorectal cancer risk (34). This evidence concerns the gene INS and colorectal cancer.